Direct polymerase chain reaction from whole blood without DNA isolation

被引:42
作者
Nishimura, N
Nakayama, T
Tonoike, H
Kojima, K
Kato, S
机构
[1] Shimadzu Corp, Technol Res Lab, Tsukuba, Ibaraki 3050031, Japan
[2] Keio Univ, Sch Med, Dept Microbiol, Shinjuku Ku, Tokyo 1600016, Japan
关键词
D O I
10.1258/0004563001899726
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Blood and other animal fluids contain a variety of substances that inhibit the polymerase chain reaction (PCR), so that isolation of DNA is generally necessary prior to PCR. We have developed a novel reagent cocktail that effectively suppresses these inhibitory substances and makes DNA isolation from blood unnecessary for PCR. When this reagent was included in the PCR mixture, DNA Fragments of the beta-globin gene could be efficiently amplified directly from human blood samples treated with various anticoagulants or PCR-inhibitory substances. We confirmed the usefulness of this cocktail by examining a large number of blood samples with various PCR primer sets. Tn addition to fresh blood, this method enabled PCR amplification from blood samples stored at 4 degrees C. - 20 degrees C or - 80 degrees C for a minimum of 1 year.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 16 条
[1]  
BURCKHARDT J, 1994, PCR METH APPL, V3, P239
[2]  
Casareale D, 1992, PCR Methods Appl, V2, P149
[3]  
Maniatis T., 1982, MOL CLONING A LAB MA
[4]   IMPROVED METHOD FOR DIRECT PCR AMPLIFICATION FROM WHOLE-BLOOD [J].
MCCUSKER, J ;
DAWSON, MT ;
NOONE, D ;
GANNON, F ;
SMITH, T .
NUCLEIC ACIDS RESEARCH, 1992, 20 (24) :6747-6747
[5]   DIRECT PCR FROM WHOLE-BLOOD, WITHOUT DNA EXTRACTION [J].
MERCIER, B ;
GAUCHER, C ;
FEUGEAS, O ;
MAZURIER, C .
NUCLEIC ACIDS RESEARCH, 1990, 18 (19) :5908-5908
[6]  
MOTOKAWA O, 1999, DNA POLYMORPHISM, V7, P34
[7]   Direct amplification of Escherichia coli O157 vero toxin genes from human faeces by the polymerase chain reaction [J].
Okamoto, H ;
Takano, E ;
Sugao, T ;
Kage, K ;
Okamoto, E ;
Nishimura, N ;
Ueda, K .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :642-648
[8]  
ONISHI H, 1994, MHC IRS S, V1, P73
[9]  
OSAWA K, 1998, MAJOR HISTOCOMPATIBI, V5, P91
[10]  
PANACCIO M, 1993, BIOTECHNIQUES, V14, P238